Back to BCRX
BENDER ROBERT & ASSOCIATES → BCRX
BENDER ROBERT & ASSOCIATES BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
3
Latest value
$198K
Q3 2026
Peak value
$226K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $180K |
| Q1 2026 | $226K |
| Q3 2026 | $198K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $198K | 23.7K | — | — |
| Q1 2026 | $226K | 23.7K | — | — |
| Q3 2025 | $180K | 23.7K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M